Position in BBNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$409,739
+$182,085 QoQ
Shares Held
26,148
+15.1% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 134 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026MetLife Investment Management, LLC holds $229,112,485 across 67 Medical Devices names. BBNX ranks #41 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
398,341 | $36,145,462 | |
| 2 | SYK |
Stryker Corp
|
78,948 | $24,855,988 | |
| 3 | MDT |
Medtronic plc
|
293,703 | $22,976,385 | |
| 4 | BRKR |
Bruker Corp
|
374,119 | $22,514,481 | |
| 5 | GMED |
Globus Medical Inc
|
275,556 | $21,771,679 | |
| 6 | BSX |
Boston Scientific Corp
|
339,986 | $14,510,602 | |
| 7 | EW |
Edwards Lifesciences Corp
|
131,633 | $11,907,521 | |
| 8 | DXCM |
Dexcom Inc
|
103,307 | $6,957,726 |
All Filings in BBNX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $409,739 | 26,148 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $227,654 | 22,720 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $692,278 | 22,720 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $451,446 | 22,720 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $121,867 | 8,370 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $102,448 | 8,370 | Shares | Defined | 2025-05-14 | |
| No filing history on record for this holder in this stock. | ||||||